Phase 0 Trial Evaluating the Effect of Temsirolimus on Known Pharmacodynamic Targets.
Phase of Trial: Phase 0
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Temsirolimus (Primary)
- Indications Cancer
- Focus Biomarker; Pharmacodynamics
- 26 Sep 2016 Last checked against ClinicalTrials.gov record.
- 15 Oct 2013 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 04 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.